We are live on ! Find out more
VIGL

Vigil Neuroscience
VIGL

Delisted

VIGL was delisted on the 4th of August, 2025.

Back to rankings

47 hedge funds and large institutions have $125M invested in Vigil Neuroscience in 2022 Q1 according to their latest regulatory filings, with 47 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

63.18% more ownership

Funds ownership: 0% → 63.18% (+63%)

Holders
47
Holders Change
+47
Holders Change %
–
% of All Funds
0.74%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.05%
New
47
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AVLSA
Atlas Venture Life Science Advisors
Massachusetts
+$77M
2
NV
Northpond Ventures
Maryland
+$55.6M
3
Citadel Advisors
Citadel Advisors
Florida
+$28.5M
4
AG
Artal Group
Luxembourg
+$14.8M
5
CAM
Cormorant Asset Management
Massachusetts
+$8.14M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$41M +$77M +5,836,874 New
NV
2
Northpond Ventures
Maryland
$29.6M +$55.6M +4,214,498 New
Citadel Advisors
3
Citadel Advisors
Florida
$14.9M +$28.5M +2,162,639 New
AG
4
Artal Group
Luxembourg
$7.88M +$14.8M +1,121,191 New
CAM
5
Cormorant Asset Management
Massachusetts
$4.21M +$8.14M +616,786 New
PBPIA
6
Pivotal bioVenture Partners Investment Advisor
California
$3.94M +$7.4M +560,595 New
RSCM
7
Rock Springs Capital Management
Maryland
$3.32M +$6.23M +471,958 New
O
8
OrbiMed
New York
$2.89M +$5.43M +411,191 New
DTC
9
Deep Track Capital
Connecticut
$2.74M +$5.14M +389,141 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$2.71M +$5.08M +385,198 New
BlackRock
11
BlackRock
New York
$2.13M +$4.01M +303,689 New
HMC
12
Harvard Management Company
Massachusetts
$2.04M +$3.82M +289,460 New
LGM
13
Logos Global Management
California
$1.45M +$2.71M +205,595 New
Barclays
14
Barclays
United Kingdom
$722K +$1.36M +102,773 New
DCM
15
DAFNA Capital Management
California
$701K +$1.32M +99,754 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$682K +$1.28M +97,080 New
Squarepoint
17
Squarepoint
New York
$606K +$1.14M +86,193 New
CCM
18
CAAS Capital Management
New York
$527K +$990K +75,000 New
Goldman Sachs
19
Goldman Sachs
New York
$519K +$974K +73,839 New
Citigroup
20
Citigroup
New York
$451K +$846K +64,094 New
Northern Trust
21
Northern Trust
Illinois
$398K +$748K +56,683 New
State Street
22
State Street
Massachusetts
$383K +$719K +54,479 New
DKCM
23
Davidson Kempner Capital Management
New York
$211K +$396K +30,000 New
LP
24
LMR Partners
United Kingdom
$194K +$365K +27,642 New
Renaissance Technologies
25
Renaissance Technologies
New York
$141K +$264K +20,041 New
1
2

VIGL Hedge Fund Activity: Q1 2022 in Review

47 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Vigil Neuroscience (VIGL) for Q1 2022, worth a combined $125M.

Buyers outnumbered sellers: 47 funds opened new VIGL positions and 0 closed out — a net gain of 47 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Atlas Venture Life Science Advisors, opening a new position worth an estimated $77M.

  • 47 institutional investors held Vigil Neuroscience (VIGL) as of Q1 2022, up from 0 in Q4 2021.
  • Funds reported $125M of Vigil Neuroscience stock for Q1 2022.
  • 47 funds opened new Vigil Neuroscience positions in Q1 2022 and 0 closed out, a net change of +47 holders.
  • The largest Vigil Neuroscience buyer in Q1 2022 was Atlas Venture Life Science Advisors, an estimated $77M added.

Based on aggregated 13F filings for Q1 2022.